Studies have shown that the KRAS mutation exists in approximately 40% of CRCs, which is related to the higher cumulative incidence of lung metastasis of CRC and is an independent predictor of lung metastasis [32]. The gene discussed is KRAS; the disease is colorectal carcinoma.